|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 304.80 ILa | +0.76% |
|
-7.41% | -5.81% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 (ILS) | 2019 (ILS) | 2020 (ILS) | 2021 (ILS) | 2022 (ILS) | 2023 (ILS) | 2024 (ILS) | 2025 (ILS) |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Cannabis Segment | 22Cr | 39Cr | 36Cr | 24Cr | 27Cr | |||||
Total Assets | 58Cr | 89Cr | 76Cr | 73Cr | 69Cr | |||||
Operating Income | 4.46Cr | 6.86Cr | 4.45Cr | -3.97Cr | 1.44Cr | |||||
Operating Income | -18.68L | -2L | -7L | 3L | -20.28L | |||||
Net Income | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Total Assets | 28.95L | 27.7L | 20.56L | 23.97L | 2L | |||||
Reconciliations | - | - | - | - | - | |||||
Total Assets | 10Cr | 6.91Cr | 2.93Cr | 2.81Cr | - | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | -29.71L | -21.28L | -4.71Cr | - | - | |||||
Operating Income | -1.16Cr | -1.56Cr | -3.82Cr | -4.07Cr | -20.52L |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 (ILS) | 2019 (ILS) | 2020 (ILS) | 2021 (ILS) | 2022 (ILS) | 2023 (ILS) | 2024 (ILS) | 2025 (ILS) |
|---|---|---|---|---|---|---|---|---|---|---|
Israel | - | - | - | - | 26Cr | |||||
Germany | - | - | - | - | 81.51L |
- Stock Market
- Stocks
- INCR Stock
- Financials InterCure Ltd.
- Business Segments
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
